| UniProt ID | PRP31_HUMAN | |
|---|---|---|
| UniProt AC | Q8WWY3 | |
| Protein Name | U4/U6 small nuclear ribonucleoprotein Prp31 | |
| Gene Name | PRPF31 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 499 | |
| Subcellular Localization | Nucleus . Nucleus speckle . Nucleus, Cajal body . Predominantly found in speckles and in Cajal bodies. | |
| Protein Description | Involved in pre-mRNA splicing as component of the spliceosome. [PubMed: 11867543] | |
| Protein Sequence | MSLADELLADLEEAAEEEEGGSYGEEEEEPAIEDVQEETQLDLSGDSVKTIAKLWDSKMFAEIMMKIEEYISKQAKASEVMGPVEAAPEYRVIVDANNLTVEIENELNIIHKFIRDKYSKRFPELESLVPNALDYIRTVKELGNSLDKCKNNENLQQILTNATIMVVSVTASTTQGQQLSEEELERLEEACDMALELNASKHRIYEYVESRMSFIAPNLSIIIGASTAAKIMGVAGGLTNLSKMPACNIMLLGAQRKTLSGFSSTSVLPHTGYIYHSDIVQSLPPDLRRKAARLVAAKCTLAARVDSFHESTEGKVGYELKDEIERKFDKWQEPPPVKQVKPLPAPLDGQRKKRGGRRYRKMKERLGLTEIRKQANRMSFGEIEEDAYQEDLGFSLGHLGKSGSGRVRQTQVNEATKARISKTLQRTLQKQSVVYGGKSTIRDRSSGTASSVAFTPLQGLEIVNPQAAEKKVAEANQKYFSSMAEFLKVKGEKSGLMST | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSLADELLA ------CCHHHHHHH | 32.06 | 28464451 | |
| 23 | Phosphorylation | EEEEGGSYGEEEEEP HHHCCCCCCCCCCCC | 31.65 | 28464451 | |
| 53 | 2-Hydroxyisobutyrylation | DSVKTIAKLWDSKMF CHHHHHHHHHCCHHH | 46.38 | - | |
| 53 | Ubiquitination | DSVKTIAKLWDSKMF CHHHHHHHHHCCHHH | 46.38 | - | |
| 58 | Ubiquitination | IAKLWDSKMFAEIMM HHHHHCCHHHHHHHH | 35.25 | 32015554 | |
| 70 | Phosphorylation | IMMKIEEYISKQAKA HHHHHHHHHHHHCHH | 9.56 | - | |
| 73 | Ubiquitination | KIEEYISKQAKASEV HHHHHHHHHCHHHHH | 44.72 | 27667366 | |
| 73 | Acetylation | KIEEYISKQAKASEV HHHHHHHHHCHHHHH | 44.72 | 25953088 | |
| 76 | Ubiquitination | EYISKQAKASEVMGP HHHHHHCHHHHHCCC | 50.37 | - | |
| 81 | Sulfoxidation | QAKASEVMGPVEAAP HCHHHHHCCCCCCCC | 4.39 | 21406390 | |
| 90 | Phosphorylation | PVEAAPEYRVIVDAN CCCCCCCEEEEEECC | 14.77 | - | |
| 140 | Ubiquitination | LDYIRTVKELGNSLD HHHHHHHHHHHHHHH | 46.76 | 29967540 | |
| 140 | 2-Hydroxyisobutyrylation | LDYIRTVKELGNSLD HHHHHHHHHHHHHHH | 46.76 | - | |
| 145 | Phosphorylation | TVKELGNSLDKCKNN HHHHHHHHHHHHCCC | 35.83 | 27067055 | |
| 148 | Ubiquitination | ELGNSLDKCKNNENL HHHHHHHHHCCCHHH | 53.02 | 29967540 | |
| 201 | Ubiquitination | ALELNASKHRIYEYV HHHHCCCHHHHHHHH | 34.20 | 29901268 | |
| 205 | Phosphorylation | NASKHRIYEYVESRM CCCHHHHHHHHHHHH | 10.93 | 27273156 | |
| 207 | Phosphorylation | SKHRIYEYVESRMSF CHHHHHHHHHHHHCH | 7.79 | 28152594 | |
| 210 | Phosphorylation | RIYEYVESRMSFIAP HHHHHHHHHHCHHCC | 24.20 | 28152594 | |
| 239 | Phosphorylation | MGVAGGLTNLSKMPA HCHHCCCCCHHCCCC | 37.07 | 21406692 | |
| 242 | Phosphorylation | AGGLTNLSKMPACNI HCCCCCHHCCCCCCE | 29.04 | 21406692 | |
| 273 | Phosphorylation | SVLPHTGYIYHSDIV CCCCCCCEEECHHHH | 10.24 | 17360941 | |
| 275 | Phosphorylation | LPHTGYIYHSDIVQS CCCCCEEECHHHHHH | 6.18 | 22817900 | |
| 298 | Ubiquitination | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
| 298 | Sumoylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
| 298 | Ubiquitination | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | 29967540 | |
| 298 | Acetylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | 25953088 | |
| 298 | Sumoylation | AARLVAAKCTLAARV HHHHHHHHHHHHHCC | 20.29 | - | |
| 307 | Phosphorylation | TLAARVDSFHESTEG HHHHCCCCCHHCCCC | 26.16 | 29507054 | |
| 321 | Ubiquitination | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | 29967540 | |
| 321 | Ubiquitination | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
| 321 | Sumoylation | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
| 321 | Sumoylation | GKVGYELKDEIERKF CCCCCCCHHHHHHHH | 41.18 | - | |
| 327 | Sumoylation | LKDEIERKFDKWQEP CHHHHHHHHCCCCCC | 45.16 | - | |
| 327 | Sumoylation | LKDEIERKFDKWQEP CHHHHHHHHCCCCCC | 45.16 | - | |
| 330 | Ubiquitination | EIERKFDKWQEPPPV HHHHHHCCCCCCCCC | 54.64 | 29967540 | |
| 338 | Ubiquitination | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | 33845483 | |
| 338 | Sumoylation | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | - | |
| 338 | Sumoylation | WQEPPPVKQVKPLPA CCCCCCCCCCCCCCC | 55.96 | - | |
| 341 | Acetylation | PPPVKQVKPLPAPLD CCCCCCCCCCCCCCC | 38.04 | 23236377 | |
| 341 | Acetylation | PPPVKQVKPLPAPLD CCCCCCCCCCCCCCC | 38.04 | - | |
| 369 | Phosphorylation | MKERLGLTEIRKQAN HHHHHCCHHHHHHHH | 27.80 | 28555341 | |
| 379 | Phosphorylation | RKQANRMSFGEIEED HHHHHHCCCHHCCCH | 27.19 | 21712546 | |
| 388 | Phosphorylation | GEIEEDAYQEDLGFS HHCCCHHHHHHHCCC | 25.42 | 28674151 | |
| 395 | Phosphorylation | YQEDLGFSLGHLGKS HHHHHCCCHHHCCCC | 31.48 | 26074081 | |
| 401 | Ubiquitination | FSLGHLGKSGSGRVR CCHHHCCCCCCCCCC | 58.99 | 32015554 | |
| 402 | Phosphorylation | SLGHLGKSGSGRVRQ CHHHCCCCCCCCCCH | 36.07 | 26074081 | |
| 404 | Phosphorylation | GHLGKSGSGRVRQTQ HHCCCCCCCCCCHHH | 30.43 | 26074081 | |
| 410 | Phosphorylation | GSGRVRQTQVNEATK CCCCCCHHHHHHHHH | 24.74 | 26074081 | |
| 416 | Phosphorylation | QTQVNEATKARISKT HHHHHHHHHHHHHHH | 21.03 | 21406692 | |
| 417 | Ubiquitination | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
| 417 | Sumoylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
| 417 (in isoform 1) | Ubiquitination | - | 42.59 | 21890473 | |
| 417 | Sumoylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | - | |
| 417 | Ubiquitination | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | 22817900 | |
| 417 | Acetylation | TQVNEATKARISKTL HHHHHHHHHHHHHHH | 42.59 | 25953088 | |
| 421 | Phosphorylation | EATKARISKTLQRTL HHHHHHHHHHHHHHH | 17.65 | 22798277 | |
| 422 | Sumoylation | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | - | |
| 422 | Sumoylation | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | - | |
| 422 | Ubiquitination | ATKARISKTLQRTLQ HHHHHHHHHHHHHHH | 51.38 | 22817900 | |
| 423 | Phosphorylation | TKARISKTLQRTLQK HHHHHHHHHHHHHHH | 22.72 | 22798277 | |
| 430 (in isoform 1) | Ubiquitination | - | 47.88 | 21890473 | |
| 430 | Sumoylation | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
| 430 | Ubiquitination | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | 22817900 | |
| 430 | Ubiquitination | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
| 430 | Sumoylation | TLQRTLQKQSVVYGG HHHHHHHHCCEEECC | 47.88 | - | |
| 432 | Phosphorylation | QRTLQKQSVVYGGKS HHHHHHCCEEECCCC | 22.15 | 23927012 | |
| 435 | Phosphorylation | LQKQSVVYGGKSTIR HHHCCEEECCCCEEE | 20.29 | 20164059 | |
| 438 | Methylation | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 30591561 | |
| 438 | Acetylation | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 25953088 | |
| 438 | Ubiquitination | QSVVYGGKSTIRDRS CCEEECCCCEEECCC | 39.81 | 32015554 | |
| 439 | Phosphorylation | SVVYGGKSTIRDRSS CEEECCCCEEECCCC | 32.13 | 23401153 | |
| 440 | Phosphorylation | VVYGGKSTIRDRSSG EEECCCCEEECCCCC | 24.42 | 23401153 | |
| 445 | Phosphorylation | KSTIRDRSSGTASSV CCEEECCCCCCCCEE | 37.09 | 23927012 | |
| 446 | Phosphorylation | STIRDRSSGTASSVA CEEECCCCCCCCEEE | 40.85 | 23927012 | |
| 448 | Phosphorylation | IRDRSSGTASSVAFT EECCCCCCCCEEEEE | 25.89 | 23927012 | |
| 450 | Phosphorylation | DRSSGTASSVAFTPL CCCCCCCCEEEEEEC | 25.78 | 23927012 | |
| 451 | Phosphorylation | RSSGTASSVAFTPLQ CCCCCCCEEEEEECC | 18.27 | 23927012 | |
| 455 | Phosphorylation | TASSVAFTPLQGLEI CCCEEEEEECCCCEE | 17.22 | 23927012 | |
| 470 | Acetylation | VNPQAAEKKVAEANQ CCHHHHHHHHHHHHH | 48.06 | 25953088 | |
| 470 | Ubiquitination | VNPQAAEKKVAEANQ CCHHHHHHHHHHHHH | 48.06 | 32015554 | |
| 471 | Ubiquitination | NPQAAEKKVAEANQK CHHHHHHHHHHHHHH | 37.88 | - | |
| 471 | Sumoylation | NPQAAEKKVAEANQK CHHHHHHHHHHHHHH | 37.88 | 28112733 | |
| 478 (in isoform 1) | Ubiquitination | - | 48.33 | 21890473 | |
| 478 | Ubiquitination | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | 22817900 | |
| 478 | Sumoylation | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | 28112733 | |
| 478 | Sumoylation | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | - | |
| 478 | Ubiquitination | KVAEANQKYFSSMAE HHHHHHHHHHHHHHH | 48.33 | - | |
| 479 | Phosphorylation | VAEANQKYFSSMAEF HHHHHHHHHHHHHHH | 10.03 | 20068231 | |
| 481 | Phosphorylation | EANQKYFSSMAEFLK HHHHHHHHHHHHHHH | 19.00 | 20068231 | |
| 482 | Phosphorylation | ANQKYFSSMAEFLKV HHHHHHHHHHHHHHH | 16.47 | 20068231 | |
| 488 | Ubiquitination | SSMAEFLKVKGEKSG HHHHHHHHHHCCCCC | 47.42 | 32015554 | |
| 490 | Ubiquitination | MAEFLKVKGEKSGLM HHHHHHHHCCCCCCC | 60.82 | - | |
| 493 | Ubiquitination | FLKVKGEKSGLMST- HHHHHCCCCCCCCC- | 59.50 | - | |
| 494 | Phosphorylation | LKVKGEKSGLMST-- HHHHCCCCCCCCC-- | 32.62 | 24732914 | |
| 498 | Phosphorylation | GEKSGLMST------ CCCCCCCCC------ | 35.69 | 24732914 | |
| 499 | Phosphorylation | EKSGLMST------- CCCCCCCC------- | 28.76 | 24732914 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRP31_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRP31_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRP31_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 600138 | Retinitis pigmentosa 11 (RP11) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379 AND THR-455, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-448 AND THR-455, ANDMASS SPECTROMETRY. | |